SELLAS Life Sciences (SLS) Shares Outstanding (Entity) (2012 - 2018)
SELLAS Life Sciences (SLS) Shares Outstanding (Entity) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | SELLAS Life Sciences | 1.96 Bn | 1.96 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 261,543.00 |
| Jun 30, 2018 | 147,670.00 |
| Mar 31, 2018 | 123,088.00 |
| Dec 31, 2017 | 46,807.00 |
| Sep 30, 2017 | 27,897.00 |
| Jun 30, 2017 | 24,977.00 |
| Mar 31, 2017 | 17,602.00 |
| Dec 31, 2016 | 6,639.00 |
| Sep 30, 2016 | 7,172.00 |
| Jun 30, 2016 | 6,083.00 |
| Mar 31, 2016 | 6,083.00 |
| Dec 31, 2015 | 5,419.00 |
| Sep 30, 2015 | 5,419.00 |
| Jun 30, 2015 | 5,379.00 |
| Mar 31, 2015 | 4,048.00 |
| Dec 31, 2014 | 4,338.00 |
| Sep 30, 2014 | 4,048.00 |
| Jun 30, 2014 | 3,956.00 |
| Mar 31, 2014 | 3,956.00 |
| Dec 31, 2013 | 3,006.00 |